3 Human immunodeficiency virus infection in pregnancy (Q58207395)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513646 AND SRC:MED&resulttype=core&format=json

13 October 2019

review article

1 reference

title

Human immunodeficiency virus infection in pregnancy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513646 AND SRC:MED&resulttype=core&format=json

13 October 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513646 AND SRC:MED&resulttype=core&format=json

13 October 2019

author name string

Kesson A

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513646 AND SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 March 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513646 AND SRC:MED&resulttype=core&format=json

Bailliere's clinical obstetrics and gynaecology

13 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513646 AND SRC:MED&resulttype=core&format=json

13 October 2019

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513646 AND SRC:MED&resulttype=core&format=json

13 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513646 AND SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

45-74

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513646 AND SRC:MED&resulttype=core&format=json

Prevalence of maternal HIV-1 infection in Thames regions: results from anonymous unlinked neonatal testing

13 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Successful treatment with ketoconazole of Cushing's syndrome in pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

IN-VITRO PRODUCTION OF HIV-SPECIFIC ANTIBODY IN CHILDREN AT RISK OF AIDS

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

The spread of HIV-1 in Africa: sexual contact patterns and the predicted demographic impact of AIDS

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Incubation periods for paediatric AIDS patients

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Immunosuppression in pregnant women infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Current and future dimensions of the HIV/AIDS pandemic in women and children.

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Vertical transmission of HTLV-III.

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Transplacental transmission of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Lack of correlation of maternal human immunodeficiency virus infection with neonatal malformations.

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Risk factors for male to female transmission of HIV. European Study Group

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Risk factors for mother-to-child transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Women, HIV, and mucosal immunity

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Delayed and defective anti-HIV IgM response in infants

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Fetoplacental passage of zidovudine

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Mother-to-infant transmission of human immunodeficiency virus type 1: association with prematurity or low anti-gp120.

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Early detection of HIV infection in a newborn

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Caring for HIV-infected women and children

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

A Controlled Study of Inhaled Pentamidine for Primary Prevention ofPneumocystis cariniiPneumonia

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Biologic factors in the sexual transmission of human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Transactivation of human immunodeficiency virus promoter by human herpesvirus 6.

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Hierarchical pattern of mucosal candida infections in HIV-seropositive women

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Transmission of HIV to heterosexual partners of infected men and women

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Host defense during pregnancy: Neutrophil chemotaxis and adherence

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

HIV replication during the first weeks of life

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Detection of HIV1 DNA in infants and children by means of the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

HIV infection and associated risk factors in female prostitutes in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Human T-cell lymphotropic virus type III (HTLV-III) embryopathy. A new dysmorphic syndrome associated with intrauterine HTLV-III infection

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

A maternally inherited superantigen encoded by a mammary tumour virus

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

HIV-1 infection of first-trimester and term human placental tissue: a possible mode of maternal-fetal transmission

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

AIDS: risk to the health profession.

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Care of women infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

The case for routinely offering prenatal testing for human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Serious infections during pregnancy among women with advanced human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Infants born to mothers seropositive for human immunodeficiency virus. Preliminary findings from a multicentre European study

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Association of cervical ectopy with heterosexual transmission of human immunodeficiency virus: results of a study of couples in Nairobi, Kenya

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Syphilis, neurosyphilis, penicillin, and AIDS.

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Immune deficiency syndrome in children

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

A Trojan Horse mechanism for the spread of visna virus in monocytes

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Slowing the spread of human immunodeficiency virus in developing countries

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Perinatal infection with human immunodeficiency virus. Specific antibody responses by the neonate

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Lack of evidence for craniofacial dysmorphism in perinatal human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Chronic vaginal candidiasis in women with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Low-dose co-trimoxazole for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus disease

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Perinatal Transmission of the Human Immunodeficiency Virus Type 1 to Infants of Seropositive Women in Zaire

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Acquired immunodeficiency syndrome in infants

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

A survey of zidovudine use in pregnant women with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Estrogens and infection.

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Prevalence of maternal HIV infection in Scotland based on unlinked anonymous testing of newborn babies

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Zidovudine-associated embryonic toxicity in mice

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Transmission of human immunodeficiency virus (HIV/HTLV-III/LAV): a review

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Pharmacokinetic disposition of zidovudine during pregnancy

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

Postnatal transmission of AIDS-associated retrovirus from mother to infant

1 reference

https://api.crossref.org/works/10.1016/S0950-3552(05)80147-6

7 January 2021

10.1016/S0950-3552(05)80147-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8513646 AND SRC:MED&resulttype=core&format=json

13 October 2019

1 reference